Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. News
  7. Summary
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/27 01:43:45 am
2.465 EUR   -1.00%
10/26European ADRs Move Higher in Tuesday Trading
MT
10/22Health Care Stocks Edging Higher Near Friday Close
MT
10/22Health Care Stocks Hanging On for Narrow Advance, Overcoming Biotechs' Decline
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Friday Trading

09/24/2021 | 11:21am EDT


© MT Newswires 2021
All news about BIOFRONTERA AG
10/26European ADRs Move Higher in Tuesday Trading
MT
10/22Health Care Stocks Edging Higher Near Friday Close
MT
10/22Health Care Stocks Hanging On for Narrow Advance, Overcoming Biotechs' Decline
MT
10/22BIOFRONTERA : receives FDA-approval of the BF-RhodoLED® XL lamp - Form 6-K
PU
10/22European ADRs Move Higher in Friday Trading
MT
10/22BIOFRONTERA : Gets US FDA Approval of Red-Light Lamp for Photodynamic Therapy
MT
10/22BIOFRONTERA AG : receives FDA-approval of the BF-RhodoLED® XL lamp
AQ
10/22Biofrontera AG Receives FDA-Approval of the BF-RhodoLED? XL Lamp
CI
10/22BIOFRONTERA : FDA Approves BF-RhodoLED XL Lamp; ADRs Up
DJ
10/21European ADRs Move Lower in Thursday Trading
MT
More news
Financials
Sales 2021 30,4 M 35,3 M 35,3 M
Net income 2021 -12,2 M -14,2 M -14,2 M
Net Debt 2021 - - -
P/E ratio 2021 -17,2x
Yield 2021 -
Capitalization 141 M 164 M 164 M
Capi. / Sales 2021 4,64x
Capi. / Sales 2022 3,58x
Nbr of Employees 159
Free-Float 46,4%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | B8F | DE0006046113 | MarketScreener
Technical analysis trends BIOFRONTERA AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 2,49 €
Average target price 6,80 €
Spread / Average Target 173%
EPS Revisions
Managers and Directors
Hermann Lübbert Chairman-Management Board & CEO
Ludwig Lutter Chief Financial Officer
Ulrich Granzer Chairman-Supervisory Board
Jürgen Christian Baumann Vice Chairman-Supervisory Board
Kevin D. Weber Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA AG-16.08%164
CSL LIMITED4.53%100 969
WUXI BIOLOGICS (CAYMAN) INC.16.73%64 238
SAMSUNG BIOLOGICS CO.,LTD.6.42%49 692
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.10.24%40 230